The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen

Henderson, Emily J., Lord, Stephen R., Close, Jacqueline C. T., Lawrence, Andrew David

, Whone, Alan and Ben-Shlomo, Yoav 2013. The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen. BMC Neurology 13 (1) , 188. 10.1186/1471-2377-13-188

Full text not available from this repository.

Official URL: http://dx.doi.org/10.1186/1471-2377-13-188

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Psychology Research Institutes & Centres > Neuroscience and Mental Health Research Institute (NMHII)
Publisher:	BioMed Central
ISSN:	1471-2377
Date of Acceptance:	11 November 2013
Last Modified:	28 Oct 2022 10:03
URI:	https://orca.cardiff.ac.uk/id/eprint/76553

Citation Data

Cited 24 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item

Altmetric

Dimensions

CORE (COnnecting REpositories)